Related Content
Search Google Scholar for:
|
|
Science 13 June 1986:
Vol. 232. no. 4756, pp. 1373 - 1378
DOI: 10.1126/science.3520819
|
|
Articles
Science, Vol 232, Issue 4756, 1373-1378
Copyright © 1986 by American Association for the Advancement of Science
The application of bone marrow transplantation to the treatment of genetic diseases
R Parkman
Genetic diseases can be treated by transplantation of either normal allogeneic bone marrow or, potentially, autologous bone marrow into which the normal gene has been inserted in vitro (gene therapy). Histocompatible allogeneic bone marrow transplantation is used for the treatment of genetic diseases whose clinical expression is restricted to lymphoid or hematopoietic cells. The therapeutic role of bone marrow transplantation in the treatment of generalized genetic diseases, especially those affecting the central nervous system, is under investigation. The response of a generalized genetic disease to allogeneic bone marrow transplantation may be predicted by experiments in vitro. Gene therapy can be used only when the gene responsible for the disease has been characterized. Success of gene therapy for a specific genetic disease may be predicted by its clinical response to allogeneic bone marrow transplantation.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Gene Therapy Fulfilling Its Promise.
- D. B. Kohn and F. Candotti (2009)
N. Engl. J. Med.
360, 518-521
| Full Text »
| PDF »
- Human Cord Blood Progenitors Sustain Thymic T-Cell Development and a Novel Form of Angiogenesis.
- L. Crisa, V. Cirulli, K. A. Smith, M. H. Ellisman, B. E. Torbett, and D. R. Salomon (1999)
Blood
94, 3928-3940
| Abstract »
| Full Text »
| PDF »
- Placental and/or Umbilical Cord Blood: An Alternative Source of Hematopoietic Stem Cells for Transplantation.
- M. S. Cairo and J. E. Wagner (1997)
Blood
90, 4665-4678
| Full Text »
| PDF »
- Enzyme Replacement Therapy.
- K. S. Roth (1997)
Clinical Pediatrics
36, 147-148
| PDF »
- Bone Marrow Transplantation for Sickle Cell Disease.
- M. C. Walters, M. Patience, W. Leisenring, J. R. Eckman, J. P. Scott, W. C. Mentzer, S. C. Davies, K. Ohene-Frempong, F. Bernaudin, D. C. Matthews, et al. (1996)
N. Engl. J. Med.
335, 369-376
| Abstract »
| Full Text »
| PDF »
- Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients.
- C. Bordignon, L. D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati, P. Panina, E. Mazzolari, D. Maggioni, C. Rossi, P. Servida, et al. (1995)
Science
270, 470-475
| Abstract »
| PDF »
- Chimerism after Liver Transplantation for Type IV Glycogen Storage Disease and Type 1 Gaucher's Disease.
- T. E. Starzl, A. J. Demetris, M. Trucco, C. Ricordi, S. Ildstad, P. I. Terasaki, N. Murase, R. S. Kendall, M. Kocova, W. A. Rudert, et al. (1993)
N. Engl. J. Med.
328, 745-749
| Abstract »
| Full Text »
- An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
- G Ferrari, S Rossini, R Giavazzi, D Maggioni, N Nobili, M Soldati, G Ungers, F Mavilio, E Gilboa, and C Bordignon (1991)
Science
251, 1363-1366
| Abstract »
| PDF »
- The Molecular Genetic Revolution: Its Impact on Clinical Neurology.
- C. S. Payne and A. D. Roses (1988)
Arch Neurol
45, 1366-1376
| Abstract »
| PDF »
- Transplantation Immunology.
- C. H. Kirkpatrick (1987)
JAMA
258, 2993-3000
| Abstract »
| PDF »
- Bone Marrow Transplantation and Intensive Care Units: A Need for Integration.
- R. Parkman (1987)
J Intensive Care Med
2, 297-298
| PDF »
- The Molecular Biology of Gaucher Disease and the Potential for Gene Therapy.
- P.V. Choudary, S. Tsuji, B.M. Martin, B.C. Guild, R.C. Mulligan, G.J. Murray, J.A. Barranger, and E.I. Ginns (1986)
Cold Spring Harb Symp Quant Biol
51, 1047-1052
| Abstract »
| PDF »
- Gene Transfer and Expression in Nonhuman Primates Using Retroviral Vectors.
- W. F. Anderson, P. Kantoff, M. Eglitis, J. McLachlin, E. Karson, J. Zwiebel, A. Nienhuis, S. Karlsson, R.M. Blaese, D. Kohn, et al. (1986)
Cold Spring Harb Symp Quant Biol
51, 1073-1081
| Abstract »
| PDF »
|
|
